[en] The cytotoxic interaction of combined 5-fluorouracil (5-FU) with different nucleoside analogues was investigated in vitro on a colon (WiDr) and a breast (MCF-7) cancer cell line. Azidothymidine (AZT), 3'-deoxy-2', 3'-didehydrothymidine (D4T), 5-iododeoxyuridine (IdUrd) and 2',3'-dideoxycytidine (DDC) were tested at different concentrations (5-600 microM) as modulators of 5-FU. The experimental endpoints were cellular viability and cell cycle distribution. The combination of 5-FU and AZT or D4T yielded supra-additive cytotoxic effects in both cell lines at all concentrations. On WiDr, IdUrd at high concentrations of 50 and 100 microM showed a supra-additive effect whereas at low concentrations (5, 10 and 20 microM) the effect was antagonistic. 5-FU combined with IdUrd produced a synergistic effect on MCF-7 cells at all concentrations. DDC antagonised the toxic effect of 5-FU on the WiDr cell line. In WiDr cells, a significant increase in the overall S-phase was observed 48 and 72 hours after exposure to D4T, AZT and DDC at the low concentration of 10 microM. On the contrary, this accumulation in S-phase was not present in MCF-7 cells. The combined effect of 5-FU and nucleoside analogues in vitro is dependent on the type and concentration of nucleosides and the cell-line tested. AZT, D4T and IdUrd are more likely to be subjected to more intensive in vitro and in vivo research as far as modulation of 5-FU toxicity is concerned.
Wadler, S., Wersto, R., Weinberg, V., Thompson, D., Schwartz, E.L., Interaction of fluorouracil and Interferon in human colon cancer cell lines: Cytotoxic and cytokinetic effects (1990) Cancer Res, 50, pp. 5735-5739
Hainsworth, J.D., The use of mitoxantrone, 5-fluorouracil and high- Dose leucovorin in the treatment of advanced breast cancer (1993) Ann Oncol, 4 (SUPPL. 2), pp. S37-S40
Naguib, E.N.M., Hao, S.N., Kouni, M.H., Potentiation of 5-fluorouracil efficacy by the dihydrouracil dehydrogenase inhibitor, 5-benzyloxybenzyluracil (1994) Cancer Res, 54, pp. 5166-5170
Brunetti, I., Falcone, A., Calabresi, P., Goulette, F.A., Darnowski, J.W., 5- Fluorouracil enhances azidothymidine cytotoxicity: In vitro, in vivo, and biochemical studies (1990) Cancer Res, 50, pp. 4026-4031
Tosi, P., Calabresi, P., Goulette, F.A., Renaud, C.A., Darnowski, J.W., Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo (1992) Cancer Res, 52, pp. 4069-4073
Weber, G., Ichikawa, S., Nagai, M., Natsumeda, Y., Azidothymidine inhibition of thymidine kinase and synergistic cytotoxicity with methotrexate and 5-fluorouracil in rat hepatoma and human colon cancer cells (1990) Cancer Commun, 2, pp. 129-133
Weber, G., Nagai, M., Prajda, N., Nakamura, H., Szekeres, T., Olah, E., AZT: A biochemical response modifier of methotrexate and 5- Fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells (1991) Cancer Commun, 3, pp. 127-132
Zhen, Y.S., Taniki, T., Weber, G., Azidothymidine and dipyridamole as biochemical response modifiers: Synergism with methotrexate and 5- Fluorouracil in human colon and pancreatic carcinoma cells (1992) Oncol Res, 4, pp. 73-78
Benson III, A.B., Trump, D.L., Cummings, K.B., Fischer, P.H., Modulation of 5-iodo-2′-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines (1985) Biochem Pharmacol, 34, pp. 3925-3931
Scanlon, K.J., Kashani-Sabet, M., Sowers, L.C., Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT-8cells and circumevention by azidothymidine (1989) Cancer Commun, 1, pp. 269-275
Szekeres, T., Findenig, G., Fritzer-Szekeres, M., Mader, R., Gobi, R., AZT is capable of modulating 5-FU resistance in human colon tumor cells (1996) Proc Am Assoc Cancer Res, 37, p. 293
Posner, M.R., Darnowski, J.W., Calabresi, P., Brunetti, I., Corvese, D., Curt, G., Cummings, F.J., Weitberg, A.B., Oral zidovudine, continuous-infusion fluorouracil, and oral leucovorin calcium: A phase I study (1990) J Natl Cancer Inst, 82, pp. 1710-1714
Posner, M.R., Darnowski, J.W., Weitberg, A.B., Dudley, M.N., Corvese, D., Cummings, F.J., Clark, J., Calabresi, P., High-dose intravenous zidovudine with 5-fluorouracil and leucovorin: A phase I trial (1992) Cancer, 70, pp. 2929-2934
Falcone, A., Danesi, R., Dargenio, F., Pfanner, E., Brunetti, I., Tacca, M.D., Nethersell, A.B.M., Conte, P.F., Intravenous azidothymidine with fluorouracil and leucovorin: A phase I-II study in previously untreated metastatic colorectal cancer patients (1996) J Clin Oncol, 14, pp. 729-736
Chang, A.E., Collins, J.M., Speth, P.A.J., Smith, R., Rowland, J.B., Campbell, L., Begley, M.G., Kinsella, T.J., Phase I study of intraarterial iododeoxyuridine in patients with colorectal liver metastases (1989) J Clin Oncol, 7, pp. 662-668
Balzarini, J., Herdewijn, P., De Clercq, E., Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′dideoxythymidine (D4T) and 3′-azido-2′,3′-dideoxythymidine (AZT), two potent antiHIV compounds (1989) J Biol Chem, 264, pp. 6127-6133
Bozzette, S.A., Kanouse, D.E., Berry, S., Duan, N., Health status and function with zidovudine or zalcitabine as initial therapy for AIDS: A randomized controlled trial. Roche 3300/ACTG 114 Study Group (1995) JAMA, 273, pp. 295-301
Denizot, F., Lang, R., Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability (1986) J Immunol Methods, 89, pp. 271-277
Chou, T.C., Talalay, P., Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs and enzyme inhibitors (1984) Adv Enzyme Regul, 22, pp. 27-55
Begg, A.C., Ncnally, N.J., Shrieve, D.C., Karcher, H., A method to measure the duration of the DNA synthesis and the potential doubling time from a single sample (1985) Cytometry, 6, pp. 620-626
McGinn, C.J., Miller, E.M., Lindstrom, M.J., Kunugi, K.A., Johnston, P.G., Kinsella, T.J., The role of cell cyle redistribution in radiosensitization: Implications regarding the mechanism of fluorodeoxyuridine radiosensitization (1994) Int J Radiat Oncol Biol Phys, 30, pp. 851-859
Darnowski, J.W., Brunetti, I., Posner, M., Weitberg, A., Falcone, A., Goulette, F., Corvese, M., Calabresi, P., Fluorouracil plus azidothymidine cytotoxicity in vitro: Relationship to cellular thymidine kinase activity (1990) Proc Am Assoc Cancer Res, 31, p. 110
Pressacco, J., Mitrovski, B., Erlichman, C., Hedley, D.W., Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expression (1995) Cancer Res, 55, pp. 1505-1508
Pressacco, J., Erlichman, C., Combination studies with 3′-azido3′- Deoxythymidine (AZT) plus ICI D1694: Cytotoxic and biochemical effects (1993) Biochem Pharmacol, 46, pp. 1989-1997
Balzarini, J., The metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives (1994) Pharm World Sci, 16, pp. 113-126
Lawrence, T.S., Davis, M.A., Maybaum, J., Stetson, P.L., Ensminger, W.D., Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cells (1992) Int J Radiat Oncol Biol Phys, 22, pp. 499-503
Kuo, M.L., Kunugi, K.A., Lindstrom, M.J., Kinsella, T.J., The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells (1995) Cancer Res, 55, pp. 2800-2805
Pressacco, J., Hedley, D.W., Erlichman, C., ICI D1694 and idoxuridine: A synergistic antitumor combination (1994) Cancer Res, 54, pp. 3772-3778
Greene, R.F., Collins, J.M., Effects of leucovorin on idoxyuridine cytotoxicity and DNA incorporation (1990) Cancer Res, 50, pp. 6652-6656
Jackman, A.L., Calvert, A.H., Folate-based thymidylate synthase inhibitors as anticancer drugs (1995) Ann Oncol, 6, pp. 871-881
